Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever).
暂无分享,去创建一个
J. Critchley | Z. Bhutta | P. Garner | P. Olliaro | E. Effa | Z. Lassi | D. Sinclair
[1] J. E. Bennett,et al. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases , 2014 .
[2] E. Mintz,et al. Ciprofloxacin-Resistant Salmonella enterica Serotype Typhi, United States, 1999–2008 , 2011, Emerging infectious diseases.
[3] J. Farrar,et al. Gatifloxacin versus chloramphenicol for uncomplicated enteric fever: an open-label, randomised, controlled trial , 2011, The Lancet. Infectious diseases.
[4] J. Wain,et al. Suitable Disk Antimicrobial Susceptibility Breakpoints Defining Salmonella enterica Serovar Typhi Isolates with Reduced Susceptibility to Fluoroquinolones , 2010, Antimicrobial Agents and Chemotherapy.
[5] S. Atukorala,et al. Enteric fever caused by Salmonella isolates with decreased susceptibility to ciprofloxacin. , 2010, The Ceylon medical journal.
[6] H. Ismail,et al. Fluoroquinolone-Resistant Typhoid, South Africa , 2010, Emerging infectious diseases.
[7] D. Moher,et al. Randomized trials published in some Chinese journals: how many are randomized? , 2009, Trials.
[8] K. Keddy,et al. Quinolone-resistant Salmonella Typhi in South Africa, 2003–2007 , 2009, Epidemiology and Infection.
[9] Varsha Gupta,et al. Re-emerging chloramphenicol sensitivity and emerging low level ciprofloxacin resistance among Salmonella enterica serotype typhi isolates in North India , 2009, Tropical doctor.
[10] A. Dashti,et al. Ciprofloxacin-Resistant Salmonella enterica Serovar Typhi from Kuwait with Novel Mutations in gyrA and parC Genes , 2008, Journal of Clinical Microbiology.
[11] J. Farrar,et al. A Multi-Center Randomised Controlled Trial of Gatifloxacin versus Azithromycin for the Treatment of Uncomplicated Typhoid Fever in Children and Adults in Vietnam , 2008, PloS one.
[12] C. Chiu,et al. Surveillance of antimicrobial resistance of Salmonella enterica serotype Typhi in seven Asian countries , 2008, Epidemiology and Infection.
[13] Tikki Pang,et al. A study of typhoid fever in five Asian countries: disease burden and implications for controls. , 2008, Bulletin of the World Health Organization.
[14] J. Crump,et al. Clinical Response and Outcome of Infection with Salmonella enterica Serotype Typhi with Decreased Susceptibility to Fluoroquinolones: a United States FoodNet Multicenter Retrospective Cohort Study , 2008, Antimicrobial Agents and Chemotherapy.
[15] J. Wain,et al. Antimicrobial Drug Resistance of Salmonella enterica Serovar Typhi in Asia and Molecular Mechanism of Reduced Susceptibility to the Fluoroquinolones , 2007, Antimicrobial Agents and Chemotherapy.
[16] J. Farrar,et al. An Open Randomized Comparison of Gatifloxacin versus Cefixime for the Treatment of Uncomplicated Enteric Fever , 2007, PloS one.
[17] Shalini,et al. Multidrug — resistant typhoid fever , 2007, Indian journal of pediatrics.
[18] J. Wain,et al. Cases of typhoid fever imported into England, Scotland and Wales (2000-2003). , 2007, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[19] S. Amarnath,et al. Fluoroquinolone resistance in Salmonella typhi and S. paratyphi A in Bangalore, India. , 2007, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[20] Edet E Udo,et al. Ciprofloxacin treatment failure in a case of typhoid fever caused by Salmonella enterica serotype Paratyphi A with reduced susceptibility to ciprofloxacin. , 2007, Journal of medical microbiology.
[21] J. Wain,et al. Randomized Controlled Comparison of Ofloxacin, Azithromycin, and an Ofloxacin-Azithromycin Combination for Treatment of Multidrug-Resistant and Nalidixic Acid-Resistant Typhoid Fever , 2006, Antimicrobial Agents and Chemotherapy.
[22] S. Rubino,et al. Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India. , 2006, The Journal of antimicrobial chemotherapy.
[23] C. Woods,et al. Emergence of Salmonella enterica serotype Paratyphi A as a major cause of enteric fever in Kathmandu, Nepal. , 2006, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[24] R. Gaind,et al. Age-related clinical and microbiological characteristics of enteric fever in India. , 2006, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[25] G. Nair,et al. Multidrug-Resistant Salmonella enterica Serovar Typhi Isolates with High-Level Resistance to Ciprofloxacin in Dhaka, Bangladesh , 2006, Antimicrobial Agents and Chemotherapy.
[26] S. Nair,et al. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets. , 2006, The Journal of antimicrobial chemotherapy.
[27] M. Rennels,et al. The Use of Systemic Fluoroquinolones , 2006, Pediatrics.
[28] J. Wain,et al. Fluoroquinolone resistance in Salmonella Typhi , 2006, BMJ : British Medical Journal.
[29] Lorenz von Seidlein,et al. The malaria and typhoid fever burden in the slums of Kolkata, India: data from a prospective community-based study. , 2006, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[30] N. Beeching,et al. Test for quinolone resistance in typhoid fever , 2006, BMJ : British Medical Journal.
[31] F. Siddiqui,et al. Typhoid fever in children: some epidemiological considerations from Karachi, Pakistan. , 2006, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[32] J. Farrar,et al. Salmonella enterica serovar Paratyphi A and S. enterica serovar Typhi cause indistinguishable clinical syndromes in Kathmandu, Nepal. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[33] V. Sharma,et al. Treatment of enteric fever in children on the basis of current trends of antimicrobial susceptibility of Salmonella enterica serovar typhi and paratyphi A. , 2006, Indian journal of medical microbiology.
[34] Alexander Kopp,et al. Outpatient gatifloxacin therapy and dysglycemia in older adults. , 2006, The New England journal of medicine.
[35] A. Kapil,et al. Antibiogram pattern and seasonality of Salmonella serotypes in a North Indian tertiary care hospital , 2006, Epidemiology and Infection.
[36] R. Frothingham. Glucose homeostasis abnormalities associated with use of gatifloxacin. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[37] J. Wain,et al. Salmonella Paratyphi A Rates, Asia , 2005, Emerging infectious diseases.
[38] A. Kapil,et al. High-level ciprofloxacin resistance in Salmonella enterica serotype Typhi in India. , 2005, Journal of medical microbiology.
[39] R. Gaind,et al. Current perspectives of enteric fever: a hospital-based study from India , 2005, Annals of tropical paediatrics.
[40] M. Salman,et al. Changing trends in drug resistance among typhoid salmonellae in Rawalpindi, Pakistan. , 2005, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.
[41] R. Bahl,et al. Typhoid and paratyphoid fever , 2005, The Lancet.
[42] M. Jesudason. Paratyphoid fever in Vellore, South India , 2005, Tropical doctor.
[43] P. Newton,et al. A randomized comparison of oral chloramphenicol versus ofloxacin in the treatment of uncomplicated typhoid fever in Laos. , 2005, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[44] K. O. Akinyemi,et al. Multidrug resistance in Salmonella enterica serovar typhi isolated from patients with typhoid fever complications in Lagos, Nigeria. , 2005, Public health.
[45] N. M. Duong,et al. Comparative trial of short-course ofloxacin for uncomplicated typhoid fever in Vietnamese children , 2005, Annals of tropical paediatrics.
[46] A. Naheed,et al. Bacteremic Typhoid Fever in Children in an Urban Slum, Bangladesh , 2005, Emerging infectious diseases.
[47] Haruo Watanabe,et al. Fluoroquinolone-resistant Salmonella Paratyphi A , 2005, Emerging infectious diseases.
[48] A. Mccarthy,et al. Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series , 2004, BMC infectious diseases.
[49] S. Parija,et al. Isolated high-level ciprofloxacin resistance in Salmonella enterica subsp. enterica serotype Paratyphi A. , 2004, Journal of medical microbiology.
[50] C. Parry. The treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever in Viet Nam. , 2004, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[51] M. Jesudason,et al. Treatment failure in typhoid fever with ciprofloxacin susceptible Salmonella enterica serotype Typhi. , 2004, Diagnostic microbiology and infectious disease.
[52] J. Crump,et al. The global burden of typhoid fever. , 2004, Bulletin of the World Health Organization.
[53] C. Hart,et al. Characterization of Multidrug-Resistant Typhoid Outbreaks in Kenya , 2004, Journal of Clinical Microbiology.
[54] A. Mahmood,et al. Ciprofloxacin Treatment Failure in Typhoid Fever Case, Pakistan , 2003, Emerging infectious diseases.
[55] P. Gerner-Smidt,et al. Trends in antimicrobial drug resistance in Salmonella enterica serotypes Typhi and Paratyphi A isolated in Europe, 1999-2001. , 2003, International journal of antimicrobial agents.
[56] D. Gendrel,et al. Fluoroquinolones in paediatrics: a risk for the patient or for the community? , 2003, The Lancet. Infectious diseases.
[57] B. Cirincione,et al. Gatifloxacin and the elderly: pharmacokinetic-pharmacodynamic rationale for a potential age-related dose reduction. , 2003, The Journal of antimicrobial chemotherapy.
[58] J. Crump,et al. Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[59] M. Bhattacharya,et al. A note on incidence of typhoid fever in diverse age groups in Kolkata, India. , 2003, Japanese journal of infectious diseases.
[60] J. V. D. van der Meer,et al. Persistence of Salmonellae in Blood and Bone Marrow: Randomized Controlled Trial Comparing Ciprofloxacin and Chloramphenicol Treatments against Enteric Fever , 2003, Antimicrobial Agents and Chemotherapy.
[61] S. Shenai,et al. Enteric fever in Mumbai, India: the good news and the bad news. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[62] J. Malone,et al. Trends of multiple-drug resistance among Salmonella serotype Typhi isolates during a 14-year period in Egypt. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[63] R. Thomson,,et al. Fluoroquinolones: considerations for future use. , 2002, The Pediatric infectious disease journal.
[64] K. Ahmad. Experts call for surveillance of drug-resistant typhoid at a global level , 2002, The Lancet.
[65] M. Levine,et al. Management of typhoid fever in children. , 2002, The Pediatric infectious disease journal.
[66] C. Oliphant,et al. Quinolones: a comprehensive review. , 2002, American family physician.
[67] D. Fish. Fluoroquinolone Adverse Effects and Drug Interactions , 2001, Pharmacotherapy.
[68] Douglas G Altman,et al. Systematic reviews in health care: Assessing the quality of controlled clinical trials. , 2001, BMJ.
[69] D. Chandel,et al. Enteric fever treatment failures: a global concern. , 2001, Emerging infectious diseases.
[70] Ryuta Kishii,et al. Contributions of the 8-Methoxy Group of Gatifloxacin to Resistance Selectivity, Target Preference, and Antibacterial Activity against Streptococcus pneumoniae , 2001, Antimicrobial Agents and Chemotherapy.
[71] E. Threlfall,et al. Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype typhi, United Kingdom. , 2001, Emerging infectious diseases.
[72] R. Black,et al. Typhoid fever in Bangladesh: implications for vaccination policy. , 2001, The Pediatric infectious disease journal.
[73] L. Loiacono,et al. Ciprofloxacin versus chloramphenicol in the treatment of salmonella infection. , 2000, International journal of antimicrobial agents.
[74] A. Pandey,et al. Drug-resistant Salmonella enterica serotype paratyphi A in India. , 2000, Emerging infectious diseases.
[75] J. Wain,et al. A Randomized Controlled Comparison of Azithromycin and Ofloxacin for Treatment of Multidrug-Resistant or Nalidixic Acid-Resistant Enteric Fever , 2000, Antimicrobial Agents and Chemotherapy.
[76] D. Fish,et al. The safety profile of the fluoroquinolones. , 2000, Clinical therapeutics.
[77] Qirong Zhu,et al. Ceftriaxone vs. norfloxacin in the treatment of resistant typhoid fever in 60 children , 2000 .
[78] R. Tauxe,et al. Laboratory-based surveillance of Salmonella serotype Typhi infections in the United States: antimicrobial resistance on the rise. , 2000, JAMA.
[79] D. D. Trach,et al. The epidemiology of typhoid fever in the Dong Thap Province, Mekong Delta region of Vietnam. , 2000, The American journal of tropical medicine and hygiene.
[80] P. Gillet,et al. Proteoglycan and Collagen Biochemical Variations during Fluoroquinolone-Induced Chondrotoxicity in Mice , 1999, Antimicrobial Agents and Chemotherapy.
[81] B. Singh,et al. Typhoid fever in children aged less than 5 years , 1999, The Lancet.
[82] L. Roberts,et al. A massive epidemic of multidrug-resistant typhoid fever in Tajikistan associated with consumption of municipal water. , 1999, The Journal of infectious diseases.
[83] T. Butler,et al. Azithromycin versus Ciprofloxacin for Treatment of Uncomplicated Typhoid Fever in a Randomized Trial in Egypt That Included Patients with Multidrug Resistance , 1999, Antimicrobial Agents and Chemotherapy.
[84] E. Threlfall,et al. Ciprofloxacin-resistant Salmonella typhi and treatment failure , 1999, The Lancet.
[85] A. Kapil,et al. Re-emergence of chloramphenicolsensitive Salmonella typhi , 1999, The Lancet.
[86] N. White,et al. A comparative study of ofloxacin and cefixime for treatment of typhoid fever in children. The Dong Nai Pediatric Center Typhoid Study Group. , 1999, The Pediatric infectious disease journal.
[87] Z. Bhutta,et al. Haemolytic uraemic syndrome in childhood: an experience of 7 years at the Aga Khan University. , 1998, JPMA. The Journal of the Pakistan Medical Association.
[88] R. Tauxe,et al. Typhoid fever in the United States, 1985-1994: changing risks of international travel and increasing antimicrobial resistance. , 1998, Archives of internal medicine.
[89] E. Threlfall,et al. Epidemic ciprofloxacin-resistant Salmonella typhi in Tajikistan , 1998, The Lancet.
[90] J. Wain,et al. Quinolone-resistant Salmonella typhi in Viet Nam: molecular basis of resistance and clinical response to treatment. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[91] C. Ağalar,et al. Comparison of two regimens for ciprofloxacin treatment of enteric infections , 1997, European Journal of Clinical Microbiology and Infectious Diseases.
[92] R. Simes,et al. Publication bias: evidence of delayed publication in a cohort study of clinical research projects , 1997, BMJ.
[93] F. Davachi,et al. Therapeutic efficacy of perfloxacin in treatment of ampicillin-resistant typhoid fever in 7 days versus 10 days , 1997 .
[94] J. Wain,et al. Short courses of ofloxacin for the treatment of enteric fever. , 1997, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[95] G. Kanra,et al. Ofloxacin versus co‐trimoxazole in the treatment of typhoid fever in children , 1997, Acta paediatrica Japonica : Overseas edition.
[96] S. Unal,et al. Treatment of enteric fever with pefloxacin for 7 days versus 5 days: a randomized clinical trial , 1996, Antimicrobial agents and chemotherapy.
[97] N. M. Dung,et al. Pharmacokinetics of oral and intravenous ofloxacin in children with multidrug-resistant typhoid fever , 1996, Antimicrobial agents and chemotherapy.
[98] Z. Bhutta,et al. Impact of age and drug resistance on mortality in typhoid fever. , 1996, Archives of disease in childhood.
[99] J. Wain,et al. Two or three days of ofloxacin treatment for uncomplicated multidrug-resistant typhoid fever in children , 1996, Antimicrobial agents and chemotherapy.
[100] John Richens. Typhoid in the highlands of Papua New Guinea 1984-1990: a hospital-based perspective. , 1995, Papua and New Guinea medical journal.
[101] E. Threlfall,et al. Ciprofloxacin-resistant Salmonella typhi in the UK , 1995, The Lancet.
[102] M. Alam,et al. Efficacy of ciprofloxacin in enteric fever: comparison of treatment duration in sensitive and multidrug-resistant Salmonella. , 1995, The American journal of tropical medicine and hygiene.
[103] V. Takkar,et al. Resurgence of chloramphenicol sensitive Salmonella typhi. , 1995, Indian pediatrics.
[104] N. M. Duong,et al. Short course of ofloxacin for treatment of multidrug-resistant typhoid. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[105] L. Imparato,et al. Pefloxacin versus chloramphenicol in the therapy of typhoid fever , 1995, Infection.
[106] U. N. Pathak,et al. Treatment of typhoid fever: randomized trial of a three-day course of ceftriaxone versus a fourteen-day course of chloramphenicol. , 1995, The American journal of tropical medicine and hygiene.
[107] Z. Bhutta,et al. Therapy of multidrug-resistant typhoid fever with oral cefixime vs. intravenous ceftriaxone. , 1994, The Pediatric infectious disease journal.
[108] M. Daga,et al. A study of culture positive multidrug resistant enteric fever--changing pattern and emerging resistance to ciprofloxacin. , 1994, The Journal of the Association of Physicians of India.
[109] N. M. Duong,et al. Comparison of ofloxacin and ceftriaxone for short-course treatment of enteric fever , 1994, Antimicrobial Agents and Chemotherapy.
[110] N. M. Duong,et al. A randomized comparative study of fleroxacin and ceftriaxone in enteric fever. , 1994, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[111] M. Millar,et al. Ciprofloxacin resistance in Salmonella paratyphi A. , 1994, The Journal of antimicrobial chemotherapy.
[112] V. Takkar,et al. Comparison of ciprofloxacin versus cephelexin and gentamicin in the treatment of multi-drug resistant typhoid fever. , 1994, Indian pediatrics.
[113] B. Bhatia,et al. Use of ciprofloxacin and its resistance in typhoid fever. , 1994, Indian pediatrics.
[114] K. Hyams,et al. Ciprofloxacin versus ceftriaxone in the treatment of multiresistant typhoid fever , 1993, European Journal of Clinical Microbiology and Infectious Diseases.
[115] M. Levine,et al. Salmonella typhi infection in children younger than five years of age. , 1993, The Pediatric infectious disease journal.
[116] N. Singh,et al. Efficacy of ciprofloxacin and norfloxacin in multidrug resistant enteric fever in adults. , 1993, Journal of the Indian Medical Association.
[117] S. Hou. [Clinical study of Chinese ofloxacin]. , 1993, Zhonghua yi xue za zhi.
[118] C. Hong,et al. Randomized comparative study of fleroxacin and chloramphenicol in typhoid fever. , 1993, The American journal of medicine.
[119] A. Uwaydah,et al. Randomized prospective study comparing two dosage regimens of ciprofloxacin for the treatment of typhoid fever. , 1992, The Journal of antimicrobial chemotherapy.
[120] G. Morelli,et al. Fluoroquinolones versus chloramphenicol in the therapy of typhoid fever: A clinical and microbiological study , 1992 .
[121] Y. Coovadia,et al. An outbreak of multiresistant Salmonella typhi in South Africa. , 1992, The Quarterly journal of medicine.
[122] R. Lasserre,et al. Three-day treatment of typhoid fever with two different doses of ceftriaxone, compared to 14-day therapy with chloramphenicol: a randomized trial. , 1991, The Journal of antimicrobial chemotherapy.
[123] P. Sarma,et al. Randomized treatment of patients with typhoid and paratyphoid fevers using norfloxacin or chloramphenicol. , 1991, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[124] Zhu By,et al. Clinical evaluation of enoxacin , 1991 .
[125] A. Bavdekar,et al. Ciprofloxacin in typhoid fever , 1991, Indian journal of pediatrics.
[126] B. Limson,et al. Comparative study of ciprofloxacin versus co-trimoxazole in the treatment of salmonella enteric fever , 1989, Infection.
[127] T. Butler,et al. Randomized treatment of patients with typhoid fever by using ceftriaxone or chloramphenicol. , 1988, The Journal of infectious diseases.
[128] H. Himmich,et al. Prospective randomized comparative trial of pefloxacin versus cotrimoxazole in the treatment of typhoid fever in adults , 1988, European Journal of Clinical Microbiology and Infectious Diseases.
[129] J. Bertrand,et al. [Evaluation of the use of ofloxacin in the treatment of various infections]. , 1986, Pathologie-biologie.
[130] H. Himmich. Comparaison de l'activité et de la tolérance de la pefloxacine et du cotrimoxazole dans le traitement de la fievre typhoide* , 1986 .
[131] Hal B. Jenson,et al. Nelson Textbook of Pediatrics , 1965 .
[132] Hendarwanto,et al. A Comparative Study of Short Course Ciprofloxacin Treatment in Typhoid and Paratyphoid Fever , 2012, Drugs.
[133] Samuel I. Miller,et al. Salmonella Species, Including Salmonella Typhi , 2010 .
[134] J. Farrar,et al. Emerging trends in enteric fever in Nepal: 9124 cases confirmed by blood culture 1993-2003. , 2008, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[135] Khie Chen,et al. Open study on efficacy and tolerability of ciprofloxacin XR compared with ciprofloxacin BID in the treatment of typhoid fever. , 2007, Acta medica Indonesiana.
[136] E. Shankar,et al. Emergence of nalidixic acid-resistant Salmonella enterica serovar Typhi resistant to ciprofloxacin in India. , 2007, Journal of medical microbiology.
[137] V. Lakshmi,et al. Changing trends in the antibiograms of Salmonella isolates at a tertiary care hospital in Hyderabad. , 2006, Indian journal of medical microbiology.
[138] J. Haq,et al. Nalidixic acid-resistant Salmonella enterica serovar Typhi with decreased susceptibility to ciprofloxacin caused treatment failure: a report from Bangladesh. , 2003, Japanese journal of infectious diseases.
[139] A. Mahmood. Multidrug resistant Salmonella paratyphi 'A'. , 2000 .
[140] P. Okonkwo,et al. Fleroxacin vs Ciprofloxacin in the Management of Typhoid Fever , 1998, Clinical drug investigation.
[141] 贾辅忠,et al. Clinical Study on Therapy of Typhoid Fever with Pefloxacin , 1995 .
[142] A. Krishna,et al. Chloramphenicol resistant enteric fever. , 1993, Journal of the Indian Medical Association.
[143] E. Gotuzzo,et al. Typhoid Fever: Evaluation of the Efficacy and Safety of Ciprofloxacin in Comparison with Chloramphenicol , 1992 .
[144] M. Akhtar,et al. Role of ciprofloxacin in typhoid fever. , 1992, JPMA. The Journal of the Pakistan Medical Association.
[145] T. Butler,et al. Patterns of morbidity and mortality in typhoid fever dependent on age and gender: review of 552 hospitalized patients with diarrhea. , 1991, Reviews of infectious diseases.
[146] S. Sahaphong,et al. Ofloxacin, a new quinolone in the treatment of genitourinary and enteric infections , 1986, Infection.
[147] D. Peyramond,et al. Bilan d'utilisation de l'ofloxacine dans le traitement d'infections variées. , 1986 .
[148] John E. Bennett,et al. Principles and practice of infectious diseases. Vols 1 and 2. , 1979 .